The bleeding risk index: A clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors

Cancer

Volumn 94, Issue 12, 2002, Pages 3252-3262

  Elting, Linda S ^a,b   Martin, Charles G ^b   Kurtin, Danna J ^b   Cantor, Scott B ^a   Rubenstein, Edward B ^b   Rodriguez, Saul ^b   Kanesan, Krishnakumari ^b   Vadhan Raj, Saroj ^b   Benjamin, Robert S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Bleeding; Clinical prediction rule; Platelet transfusion; Thombocytopenia

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; SOLID TUMOR; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

FEMALE; HEMORRHAGE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PLATELET TRANSFUSION; RISK FACTORS;

EID: 0037096863     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10603     Document Type: Article

References (24)

1. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia
2. Incidence of hemorrhagic complications in patients with cancer
3. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors
4. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer
5. Conservative management of chemotherapy-induced thrombocytopenia in women with gynecologic cancers
6. An iconoclastic view of conventional wisdom in hematology
7. Platelet transfusions: The 20,000/μL trigger
8. Controversies in transfusion medicine - Prophylactic platelet transfusion therapy: Pro
9. Prophylactic platelet transfusion
10. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients
11. Consensus conference on platelet transfusion, Royal College of Physicians of Edinburgh
12. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/ml versus 20,000/ml
13. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia
14. 9/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukemia
15. A randomized placebo controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy
16. Randomized placebo controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin
17. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative trial of nitrogen mustard and trimethylene thiophosphoramide
18. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
19. Clinical factors influencing the efficacy of pooled platelet transfusions
20. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
21. Clinical prediction rules: Applications and methodological standards
22. A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy
23. Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors